Suppr超能文献

预测肝移植术后单发肝细胞癌的早期复发。

Prediction of Early Recurrence of Solitary Hepatocellular Carcinoma after Orthotopic Liver Transplantation.

机构信息

Clinical-Pathology Center, Bejing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.

General Surgical Center, Bejing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

Sci Rep. 2019 Nov 1;9(1):15855. doi: 10.1038/s41598-019-52427-8.

Abstract

Hepatocellular carcinomas(HCC) consisted of heterogeneous subtypes with different recurrence probabilities after liver transplantation(LT). Our study aimed to develop an improved model for predicting the recurrence of solitary HCC after LT. In this retrospective study, 151 solitary HCC patients who received orthotopic LT over a period of 10 consecutive years were included. All recipients received graft from deceased donors. The first eligible 50 patients were used as validation cohort and others were utilized to construct the model. A two-tailed P < 0.05 was considered to indicate statistical significance for all analysis. Based on the maximisation of the Youden's index, the optimal cutoff values for alpha-fetoprotein(AFP) and tumor diameter were 261.6 ng/mL and 3.6 cm, respectively. Vascular involvement includes gross and microscopic vascular invasion. Variables potentially affecting recurrence-free survival(RFS) were examined using univariate and multivariate Cox regression analysis. Univariate and multivariate analysis revealed that AFP, tumor diameter, vascular invasion and cytokeratin-19/glypican-3 sub-typing were independent prognostic factors for RFS, thus comprised the risk scoring model. The AUC values of the model in the cohorts were significantly higher than that of the Milan, UCSF, Fudan and Hangzhou criteria. These findings suggest the model has high performance in predicting early recurrence of solitary HCC patients after LT.

摘要

肝细胞癌(HCC)由不同复发概率的异质亚型组成,肝移植(LT)后存在复发风险。本研究旨在建立一种改进的模型,用于预测 LT 后单发 HCC 的复发情况。在这项回顾性研究中,纳入了 10 年间接受原位 LT 的 151 例单发 HCC 患者。所有受者均接受了来自已故供者的移植物。首先纳入前 50 例患者作为验证队列,其余患者用于构建模型。所有分析均以双侧 P<0.05 为具有统计学意义。基于 Youden 指数的最大化,甲胎蛋白(AFP)和肿瘤直径的最佳截断值分别为 261.6ng/mL 和 3.6cm。血管侵犯包括肉眼和镜下血管侵犯。使用单因素和多因素 Cox 回归分析来检查可能影响无复发生存(RFS)的变量。单因素和多因素分析显示,AFP、肿瘤直径、血管侵犯和细胞角蛋白 19/聚糖 3 分型是 RFS 的独立预后因素,因此构成了风险评分模型。该模型在队列中的 AUC 值明显高于米兰、旧金山、复旦和杭州标准。这些发现表明,该模型在预测 LT 后单发 HCC 患者的早期复发方面具有较高的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c03d/6825189/1cb12f98f39f/41598_2019_52427_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验